46 filings
6-K
PHVS
Pharvaris NV
10 Apr 24
Pharvaris Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
4:11pm
6-K
PHVS
Pharvaris NV
6 Mar 24
Current report (foreign)
4:15pm
6-K
PHVS
Pharvaris NV
16 Feb 24
Pharvaris Announces Extraordinary Meeting of Shareholders
6:51am
6-K
PHVS
Pharvaris NV
7 Feb 24
Registration Rights Agreement
4:01pm
6-K
PHVS
Pharvaris NV
22 Jan 24
Pharvaris Announces FDA Lifting of the Clinical Hold of Deucrictibant for the Prophylactic Treatment of HAE Attacks
6:51am
6-K
qlbzz
8 Jan 24
Current report (foreign)
7:00am
6-K
rvpf flxomk8tvyn9
8 Dec 23
Current report (foreign)
4:50pm
6-K
j53ppsn9qxhw2
6 Dec 23
Current report (foreign)
6:52am
6-K
nxociq68hdy
2 Nov 23
Pharvaris Reports Third Quarter 2023 Financial Results and Provides Business Update
6:51am
6-K
glsdro
7 Aug 23
Pharvaris Reports Second Quarter 2023 Financial Results and Provides Business Update
6:51am
6-K
wof87ncuwg4
3 Jul 23
Current report (foreign)
6:50am
6-K
194ve1y5742c095ctwg
27 Jun 23
Current report (foreign)
6:50am
6-K
e3tsz6mbqkgq j5nhj1
26 Jun 23
Pharvaris Announces FDA Removal of Clinical Hold of Deucrictibant for the On-Demand Treatment of HAE
6:50am
6-K
dxdmqrg
23 Jun 23
Current report (foreign)
10:25am
6-K
qyuk9
20 Jun 23
Current report (foreign)
6:50am
6-K
u23c0op
1 Jun 23
Pharvaris Announces Annual Meeting of Shareholders
6:51am
6-K
axf0xxe 3q
8 May 23
Pharvaris Reports First Quarter 2023 Financial Results and Provides Business Update
6:51am
6-K
2cmmu7ezgy81
5 Apr 23
Pharvaris Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
6:53am
6-K
jpwcn52brlcf299d
10 Mar 23
Current report (foreign)
4:43pm
6-K
sfxl75v8ps
8 Mar 23
Current report (foreign)
4:31pm